Annual Accounts Receivable
$25.18 M
-$47.79 M-65.49%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual accounts receivable is $25.18 million, with the most recent change of -$47.79 million (-65.49%) on December 31, 2023.
- During the last 3 years, ADCT annual accounts receivable has risen by +$25.18 million (+100.00%).
- ADCT annual accounts receivable is now -65.49% below its all-time high of $72.97 million, reached on December 31, 2022.
Performance
ADCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$24.03 M
+$1.16 M+5.08%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly accounts receivable is $24.03 million, with the most recent change of +$1.16 million (+5.08%) on September 30, 2024.
- Over the past year, ADCT quarterly accounts receivable has dropped by -$1.15 million (-4.57%).
- ADCT quarterly accounts receivable is now -67.07% below its all-time high of $72.97 million, reached on December 31, 2022.
Performance
ADCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ADCT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.5% | -4.6% |
| 3 y3 years | +100.0% | -20.5% |
| 5 y5 years | +10000.0% | -20.5% |
ADCT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.5% | at low | -67.1% | +15.2% |
| 5 y | 5-year | -65.5% | -100.0% | -67.1% | -100.0% |
| alltime | all time | -65.5% | -100.0% | -67.1% | -100.0% |
ADC Therapeutics SA Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.03 M(+5.1%) |
| Jun 2024 | - | $22.87 M(-1.4%) |
| Mar 2024 | - | $23.19 M(-7.9%) |
| Dec 2023 | $25.18 M(-65.5%) | $25.18 M(+18.9%) |
| Sep 2023 | - | $21.18 M(-11.3%) |
| Jun 2023 | - | $23.87 M(-0.7%) |
| Mar 2023 | - | $24.04 M(-67.1%) |
| Dec 2022 | $72.97 M | $72.97 M(+213.8%) |
| Sep 2022 | - | $23.25 M(+11.4%) |
| Jun 2022 | - | $20.86 M(-22.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $26.75 M(-11.5%) |
| Dec 2021 | $30.22 M(>+9900.0%) | $30.22 M(+90.1%) |
| Sep 2021 | - | $15.90 M(+664.6%) |
| Jun 2021 | - | $2.08 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2019 | - | $3000.00(-98.4%) |
| Dec 2018 | $192.00 K(-82.3%) | - |
| Dec 2018 | - | $192.00 K |
| Dec 2017 | $1.09 M(-81.6%) | - |
| Dec 2016 | $5.91 M | - |
FAQ
- What is ADC Therapeutics SA annual accounts receivable?
- What is the all time high annual accounts receivable for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual accounts receivable year-on-year change?
- What is ADC Therapeutics SA quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly accounts receivable year-on-year change?
What is ADC Therapeutics SA annual accounts receivable?
The current annual accounts receivable of ADCT is $25.18 M
What is the all time high annual accounts receivable for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual accounts receivable is $72.97 M
What is ADC Therapeutics SA annual accounts receivable year-on-year change?
Over the past year, ADCT annual accounts receivable has changed by -$47.79 M (-65.49%)
What is ADC Therapeutics SA quarterly accounts receivable?
The current quarterly accounts receivable of ADCT is $24.03 M
What is the all time high quarterly accounts receivable for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly accounts receivable is $72.97 M
What is ADC Therapeutics SA quarterly accounts receivable year-on-year change?
Over the past year, ADCT quarterly accounts receivable has changed by -$1.15 M (-4.57%)